MetaCap

Evommune Statistics

NYSE: EVMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.22-0.39 (-5.90%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 6.22 0.00%

Evommune by the numbers

Evommune has a market capitalization of $225.7 million based on 36.29M shares outstanding. With trailing EPS of $-3.75, Evommune is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.8% below its 50-day average and 67.0% below its 200-day average.

Average daily trading volume is 682.82K shares, or about $4.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EVMN valuation vs. peer median

EVMN compared with the median of 8 peer companies
MetricEVMNPeer medianDifference
Market cap$225.74M$240.54M-6%
Avg. volume682.82K271.10K+152%

Peer median across 8 companies: VOGX, PYXS, CAMP, QTTB, AKBA, VCRE, LFCR, SLGL.

Valuation

Market cap
$225.74M
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
$-3.75
Shares outstanding
36.29M

Price and trading

Previous close
6.61
Open
6.51
Day range
6.15 – 6.53
52-week range
6.08 – 33.20
50-day moving average
11.48
200-day moving average
18.85
Beta
—
Volume
2.11M
Average volume
682.82K

Dividends and events

Annual dividend
None
Dividend yield
—
Ex-dividend date
—
Next earnings date
Aug 6, 2026

Additional statistics

Market Cap
225.74M
Forward Pe
-1.76
Eps
-3.75
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
33.20
Week52 Low
6.08
Avg Volume
682.82K
Shares Outstanding
36.29M
Ma50
11.48
Ma200
18.85
Earnings Date
Aug 6, 2026
Pct From52w High
-81.27%
Pct From52w Low
2.30%

Related